MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with S

Sodium valproate

Sodium valproate 100mg tablets

Incompatible

Stability notes for Sodium valproate 100mg tablets

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Supplier

Epilim 100mg crushable tablets (Sanofi)

Sodium valproate 150mg modified-release capsules

Incompatible

Stability notes for Sodium valproate 150mg modified-release capsules

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Supplier

Episenta 150mg modified-release capsules (Desitin Pharma Ltd)

Sodium valproate 200mg gastro-resistant tablets

Incompatible

Stability notes for Sodium valproate 200mg gastro-resistant tablets

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Suppliers (4) of Sodium valproate 200mg gastro-resistant tablets
Epilim 200 gastro-resistant tablets (Sanofi)
Sodium valproate 200mg gastro-resistant tablets (A A H Pharmaceuticals Ltd)
Sodium valproate 200mg gastro-resistant tablets (Alliance Healthcare (Distribution) Ltd)
Sodium valproate 200mg gastro-resistant tablets (Wockhardt UK Ltd)

Sodium valproate 200mg modified-release tablets

Incompatible

Stability notes for Sodium valproate 200mg modified-release tablets

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Suppliers (4) of Sodium valproate 200mg modified-release tablets
Dyzantil 200mg modified-release tablets (Aspire Pharma Ltd)
Epilim Chrono 200 tablets (CST Pharma Ltd)
Epilim Chrono 200 tablets (Sanofi)
Epilim Chrono 200 tablets (Sigma Pharmaceuticals Plc)

Sodium valproate 300mg modified-release capsules

Incompatible

Stability notes for Sodium valproate 300mg modified-release capsules

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Suppliers

Episenta 300mg modified-release capsules (Desitin Pharma Ltd)
Episenta 300mg modified-release capsules (Necessity Supplies Ltd)

Sodium valproate 300mg modified-release tablets

Incompatible

Stability notes for Sodium valproate 300mg modified-release tablets

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Suppliers (5) of Sodium valproate 300mg modified-release tablets
Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd)
Epilim Chrono 300 tablets (CST Pharma Ltd)
Epilim Chrono 300 tablets (Sanofi)
Epilim Chrono 300 tablets (Sigma Pharmaceuticals Plc)
Epival CR 300mg tablets (G.L. Pharma UK Ltd)

Sodium valproate 500mg gastro-resistant tablets

Incompatible

Stability notes for Sodium valproate 500mg gastro-resistant tablets

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Suppliers (4) of Sodium valproate 500mg gastro-resistant tablets
Epilim 500 gastro-resistant tablets (Sanofi)
Sodium valproate 500mg gastro-resistant tablets (A A H Pharmaceuticals Ltd)
Sodium valproate 500mg gastro-resistant tablets (Alliance Healthcare (Distribution) Ltd)
Sodium valproate 500mg gastro-resistant tablets (Wockhardt UK Ltd)

Sodium valproate 500mg modified-release tablets

Incompatible

Stability notes for Sodium valproate 500mg modified-release tablets

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Suppliers (5) of Sodium valproate 500mg modified-release tablets
Dyzantil 500mg modified-release tablets (Aspire Pharma Ltd)
Epilim Chrono 500 tablets (CST Pharma Ltd)
Epilim Chrono 500 tablets (Sanofi)
Epilim Chrono 500 tablets (Sigma Pharmaceuticals Plc)
Epival CR 500mg tablets (G.L. Pharma UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.